Dipòsit Digital de Documents de la UAB 3 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
7 p, 1.3 MB The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome / Pérez de Llano, Luis (Pneumology Service. Hospital Lucus Augusti. EOXI Lugo. Cervo e Monforte) ; Dacal Rivas, David (Hospital Universitario Lucus Augusti (Lugo)) ; Malanda, Nuria Marina (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Gullón, José Antonio (Hospital Universitario Lucus Augusti (Lugo)) ; Muñoz-Esquerre, Mariana (Institut d'Investigació Biomèdica de Bellvitge) ; García-Moguel, Ismael (Allergy Service) ; Díaz Campos, Rocío Magdalena (Hospital Universitario) ; Martínez-Moragón, Eva (Hospital Universitari Doctor Peset (València)) ; Harbenau Mena, Alicia (Hospital de Mérida) ; Cosio, Borja G (Institut d'Investigació Sanitària Illes Balears) ; Padilla, Alicia (Hospital Costa del Sol (Marbella)) ; Cisneros, Carolina (Hospital Universitario de la Princesa (Madrid))
Although biologics have demonstrated to be effective in T2-high asthma patients, there is little experience with these drugs in asthma-COPD overlap (ACO). The aim of this study was to compare the effectiveness of biologics in these two conditions. [...]
2022 - 10.2147/JAA.S338467
Journal of Asthma and Allergy, Vol. 15 (2022) , p. 363-369  
2.
3 p, 634.4 KB Sudan red dye : a new agent causing type-2 occupational asthma / Clofent, David (Hospital Universitari Vall d'Hebron) ; de Homdedeu, Miquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Muñoz-Esquerre, Mariana (Institut d'Investigació Biomèdica de Bellvitge) ; Cruz Carmona, María Jesús (Hospital Universitari Vall d'Hebron) ; Muñoz Gall, Xavier (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight azoic agent widely used in industry, particularly in the production of hair dyes. The use of this product in the food industry is prohibited due to its potential carcinogenic effect, but no respiratory involvement has been reported to date. [...]
2020 - 10.1186/s13223-020-0404-8
Allergy, asthma, and clinical immunology, Vol. 16 (january 2020)  
3.
11 p, 303.7 KB Treatment of patients with COPD and recurrent exacerbations : the role of infection and inflammation / Santos, Salud (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Marín, Alicia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Serra-Batlles, Joan (Hospital Universitari de Vic) ; de la Rosa Carrillo, David (Hospital Plató) ; Solanes, Ingrid (Institut d'Investigació Biomèdica Sant Pau) ; Pomares, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; López-Sánchez, Marta (Hospital Universitari de Bellvitge) ; Muñoz-Esquerre, Mariana (Hospital Universitari de Bellvitge) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Exacerbations of COPD represent an important medical and health care problem. Certain susceptible patients suffer recurrent exacerbations and as a consequence have a poorer prognosis. The effects of bronchial infection, either acute or chronic, and of the inflammation characteristic of the disease itself raise the question of the possible role of antibiotics and anti-inflammatory agents in modulating the course of the disease. [...]
2016 - 10.2147/COPD.S98333
International journal of COPD, Vol. 11 (march 2016) , p. 515-525  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.